Matches in SemOpenAlex for { <https://semopenalex.org/work/W3046175168> ?p ?o ?g. }
- W3046175168 endingPage "770" @default.
- W3046175168 startingPage "759" @default.
- W3046175168 abstract "Abstract Purpose For optimal management of ductal carcinoma in situ (DCIS), reproducible histopathological assessment is essential to distinguish low-risk from high-risk DCIS. Therefore, we analyzed interrater reliability of histopathological DCIS features and assessed their associations with subsequent ipsilateral invasive breast cancer (iIBC) risk. Methods Using a case-cohort design, reliability was assessed in a population-based, nationwide cohort of 2767 women with screen-detected DCIS diagnosed between 1993 and 2004, treated by breast-conserving surgery with/without radiotherapy (BCS ± RT) using Krippendorff’s alpha (KA) and Gwet’s AC2 (GAC2). Thirty-eight raters scored histopathological DCIS features including grade (2-tiered and 3-tiered), growth pattern, mitotic activity, periductal fibrosis, and lymphocytic infiltrate in 342 women. Using majority opinion-based scores for each feature, their association with subsequent iIBC risk was assessed using Cox regression. Results Interrater reliability of grade using various classifications was fair to moderate, and only substantial for grade 1 versus 2 + 3 when using GAC2 (0.78). Reliability for growth pattern (KA 0.44, GAC2 0.78), calcifications (KA 0.49, GAC2 0.70) and necrosis (KA 0.47, GAC2 0.70) was moderate using KA and substantial using GAC2; for (type of) periductal fibrosis and lymphocytic infiltrate fair to moderate estimates were found and for mitotic activity reliability was substantial using GAC2 (0.70). Only in patients treated with BCS-RT, high mitotic activity was associated with a higher iIBC risk in univariable analysis (Hazard Ratio (HR) 2.53, 95% Confidence Interval (95% CI) 1.05–6.11); grade 3 versus 1 + 2 (HR 2.64, 95% CI 1.35–5.14) and a cribriform/solid versus flat epithelial atypia/clinging/(micro)papillary growth pattern (HR 3.70, 95% CI 1.34–10.23) were independently associated with a higher iIBC risk. Conclusions Using majority opinion-based scores, DCIS grade, growth pattern, and mitotic activity are associated with iIBC risk in patients treated with BCS-RT, but interrater variability is substantial. Semi-quantitative grading, incorporating and separately evaluating nuclear pleomorphism, growth pattern, and mitotic activity, may improve the reliability and prognostic value of these features." @default.
- W3046175168 created "2020-08-03" @default.
- W3046175168 creator A5003751896 @default.
- W3046175168 creator A5004571035 @default.
- W3046175168 creator A5009908756 @default.
- W3046175168 creator A5010820310 @default.
- W3046175168 creator A5012843588 @default.
- W3046175168 creator A5015859540 @default.
- W3046175168 creator A5018081434 @default.
- W3046175168 creator A5018986502 @default.
- W3046175168 creator A5019065342 @default.
- W3046175168 creator A5020517461 @default.
- W3046175168 creator A5029061749 @default.
- W3046175168 creator A5030791431 @default.
- W3046175168 creator A5034025853 @default.
- W3046175168 creator A5034061890 @default.
- W3046175168 creator A5034338334 @default.
- W3046175168 creator A5039788677 @default.
- W3046175168 creator A5045958709 @default.
- W3046175168 creator A5051767811 @default.
- W3046175168 creator A5057978312 @default.
- W3046175168 creator A5062720007 @default.
- W3046175168 creator A5064140608 @default.
- W3046175168 creator A5065916841 @default.
- W3046175168 creator A5068850297 @default.
- W3046175168 creator A5070619938 @default.
- W3046175168 creator A5076006564 @default.
- W3046175168 creator A5077599850 @default.
- W3046175168 creator A5079593398 @default.
- W3046175168 creator A5083051077 @default.
- W3046175168 creator A5084613092 @default.
- W3046175168 creator A5085734287 @default.
- W3046175168 creator A5087412490 @default.
- W3046175168 date "2020-07-30" @default.
- W3046175168 modified "2023-10-14" @default.
- W3046175168 title "Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study" @default.
- W3046175168 cites W1530262360 @default.
- W3046175168 cites W1867337880 @default.
- W3046175168 cites W189760652 @default.
- W3046175168 cites W1957162308 @default.
- W3046175168 cites W1968325773 @default.
- W3046175168 cites W1968667761 @default.
- W3046175168 cites W1974427392 @default.
- W3046175168 cites W1979020186 @default.
- W3046175168 cites W1996290308 @default.
- W3046175168 cites W2004742825 @default.
- W3046175168 cites W2010871781 @default.
- W3046175168 cites W2011575012 @default.
- W3046175168 cites W2027138642 @default.
- W3046175168 cites W2029703151 @default.
- W3046175168 cites W2057418448 @default.
- W3046175168 cites W2061504941 @default.
- W3046175168 cites W2076590252 @default.
- W3046175168 cites W2101843767 @default.
- W3046175168 cites W2107123617 @default.
- W3046175168 cites W2112507926 @default.
- W3046175168 cites W2119349383 @default.
- W3046175168 cites W2126212561 @default.
- W3046175168 cites W2130192648 @default.
- W3046175168 cites W2148309496 @default.
- W3046175168 cites W2149912051 @default.
- W3046175168 cites W2164777277 @default.
- W3046175168 cites W2168236234 @default.
- W3046175168 cites W2169491501 @default.
- W3046175168 cites W2321334062 @default.
- W3046175168 cites W2345358625 @default.
- W3046175168 cites W2517616992 @default.
- W3046175168 cites W267005183 @default.
- W3046175168 cites W2800794375 @default.
- W3046175168 cites W2888851173 @default.
- W3046175168 cites W2905427171 @default.
- W3046175168 cites W2913333529 @default.
- W3046175168 cites W2921149595 @default.
- W3046175168 cites W2941732875 @default.
- W3046175168 cites W2952690805 @default.
- W3046175168 cites W2966656188 @default.
- W3046175168 cites W2967444033 @default.
- W3046175168 cites W2973452191 @default.
- W3046175168 cites W2990117764 @default.
- W3046175168 doi "https://doi.org/10.1007/s10549-020-05816-x" @default.
- W3046175168 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7497690" @default.
- W3046175168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32734520" @default.
- W3046175168 hasPublicationYear "2020" @default.
- W3046175168 type Work @default.
- W3046175168 sameAs 3046175168 @default.
- W3046175168 citedByCount "15" @default.
- W3046175168 countsByYear W30461751682021 @default.
- W3046175168 countsByYear W30461751682022 @default.
- W3046175168 countsByYear W30461751682023 @default.
- W3046175168 crossrefType "journal-article" @default.
- W3046175168 hasAuthorship W3046175168A5003751896 @default.
- W3046175168 hasAuthorship W3046175168A5004571035 @default.
- W3046175168 hasAuthorship W3046175168A5009908756 @default.
- W3046175168 hasAuthorship W3046175168A5010820310 @default.
- W3046175168 hasAuthorship W3046175168A5012843588 @default.
- W3046175168 hasAuthorship W3046175168A5015859540 @default.
- W3046175168 hasAuthorship W3046175168A5018081434 @default.
- W3046175168 hasAuthorship W3046175168A5018986502 @default.